Posted By Kieran Beauchamp On 11 Apr 2026 Comments (7)
Learn how serious adverse events are reported for generic drugs, the regulatory requirements of the FDA and EMA, and why a significant reporting gap exists.
READ MORE
Posted By Kieran Beauchamp On 14 Feb 2026 Comments (10)
Many dangerous drug interactions are only found after medications hit the market. Learn how post-market surveillance works, why clinical trials miss these risks, and what you can do to protect yourself.
READ MORE